Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion : importance of early and complete infarct artery reperfusion

作者: R.J. Simes , Eric J. Topol , David R. Holmes , Harvey D. White , Wolfgang R. Rutsch

DOI: 10.1161/01.CIR.91.7.1923

关键词:

摘要: Background The Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial was designed to test whether thrombolytic strategies achieving more complete, early, sustained coronary artery patency would lead further reductions in mortality patients with acute myocardial infarction. An angiographic substudy within GUSTO-I provided a unique opportunity examine the relation between degrees among regimens. Methods Results Four were compared 41 021 GUSTO-I: streptokinase subcutaneous or intravenous heparin, accelerated tissue plasminogen activator (TPA) combination plus heparin. Accelerated associated lower 30-day (6.3%) than other (7.2%, 7.4%, 7.0%, respectively). Among 1210 randomized angiography 90 minutes after starting treatment, there improved patency, particularly Thrombolysis Myocardial Infarction (TIMI) grade 3 flow, over regimens ( P <.0001). perfusion (TIMI 3) at also significant predictor survival <.01). To determine differences four matched 90-minute model developed predicting main from substudy. assumed that any treatment effects on mediated through treatments. predicted rates then observed remaining each group. treatments 7.46% versus 7.28%; 7.26% 7.39%; TPA, 6.31% 6.37%; 6.98% 6.96%. correlation results .97, proportion squared error explained R 2) .92. Conclusions close supports concept an important mechanism therapy is achievement complete perfusion. match provides strong biological explanation seen sound rationale additional advantage regimen. Irrespective which used, early restoration infarct represents essential goal reperfusion therapy.

参考文章(31)
R.G. Wilcox, C.G. Olsson, A.M. Skene, G. Von Der Lippe, G. Jensen, J.R. Hampton, For The Asset Study Group, TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) The Lancet. ,vol. 332, pp. 525- 530 ,(1988) , 10.1016/S0140-6736(88)92656-6
GRUPPOITALIANOPERLOSTUDIODELL, EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION The Lancet. ,vol. 327, pp. 397- 402 ,(1986) , 10.1016/S0140-6736(86)92368-8
Karl-Ludwig Neuhaus, Rainer Von Essen, Ulrich Tebbe, Albrecht Vogt, Michael Roth, Michael Riess, Walter Niederer, Florian Forycki, Alexander Wirtzfeld, Wolfgang Maeurer, Peter Limbourg, Wolfgang Merx, Klaus Haerten, Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) Journal of the American College of Cardiology. ,vol. 19, pp. 885- 891 ,(1992) , 10.1016/0735-1097(92)90265-O
K. Peter Rentrop, Frederick Feit, Heinrich Blanke, Peter Stecy, Richard Schneider, Mariano Rey, Steven Horowitz, Martin Goldman, Karl Karsch, Henry Meilman, Marc Cohen, Stephen Siegel, Joseph Sanger, James Slater, Richard Gorlin, Arthur Fox, Richard Fagerstrom, W. Ford Calhoun, Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial Infarction The New England Journal of Medicine. ,vol. 311, pp. 1457- 1463 ,(1984) , 10.1056/NEJM198412063112301
Thomas C Wall, Robert M Califf, Barry S George, Stephen G Ellis, Joseph K Samaha, Dean J Kereiakes, Seth J Worley, Kristina Sigmon, Eric J Topol, TAMI-7 Study Group, Accelerated plasminogen activator dose regimens for coronary thrombolysis Journal of the American College of Cardiology. ,vol. 19, pp. 482- 489 ,(1992) , 10.1016/S0735-1097(10)80259-1
Maarten L. Simoons, Patrick W. Serruys, Marcel van den Brand, Jan Res, Freek W.A. Verheugt, X. Hanno Krauss, Willem J. Remme, Frits Bär, Chris de Zwaan, Arnoud van der Laarse, Frank Vermeer, Jacobus Lubsen, Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. Journal of the American College of Cardiology. ,vol. 7, pp. 717- 728 ,(1986) , 10.1016/S0735-1097(86)80329-1
D P de Bono, M L Simoons, J Tijssen, A E Arnold, A Betriu, C Burgersdijk, L Lopez Bescos, E Mueller, M Pfisterer, F Van de Werf, Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Heart. ,vol. 67, pp. 122- 128 ,(1992) , 10.1136/HRT.67.2.122